These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 26670060
1. Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience. Singh M, Wang NC, Jain S, Voigt AH, Saba S, Adelstein EC. J Am Coll Cardiol; 2015 Dec 15; 66(23):2607-2613. PubMed ID: 26670060 [Abstract] [Full Text] [Related]
2. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study. Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C. Clin Cardiol; 2017 Aug 15; 40(8):586-590. PubMed ID: 28333373 [Abstract] [Full Text] [Related]
3. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting. Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M. BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442 [Abstract] [Full Text] [Related]
4. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I. Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618 [Abstract] [Full Text] [Related]
5. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator. Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V. Heart Rhythm; 2018 Sep 27; 15(9):1379-1386. PubMed ID: 29678779 [Abstract] [Full Text] [Related]
6. A real world wearable cardioverter defibrillator experience - Very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center. Beiert T, Malotki R, Kraemer N, Stöckigt F, Linhart M, Nickenig G, Schrickel JW, Andrié RP. J Electrocardiol; 2017 Sep 27; 50(5):603-609. PubMed ID: 28499628 [Abstract] [Full Text] [Related]
7. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients. Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB. Circ Arrhythm Electrophysiol; 2018 Jul 27; 11(7):e006163. PubMed ID: 29945928 [Abstract] [Full Text] [Related]
8. National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy. Lamichhane M, Gardiner JC, Bianco NR, Szymkiewicz SJ, Thakur RK. J Interv Card Electrophysiol; 2017 Jan 27; 48(1):11-19. PubMed ID: 27752809 [Abstract] [Full Text] [Related]
9. The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis. Salehi N, Nasiri M, Bianco NR, Opreanu M, Singh V, Satija V, Jhand AS, Karapetyan L, Safadi AR, Surapaneni P, Thakur RK. Can J Cardiol; 2016 Oct 27; 32(10):1247.e1-1247.e6. PubMed ID: 26975224 [Abstract] [Full Text] [Related]
10. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland. Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F. Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723 [Abstract] [Full Text] [Related]
11. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. Skowasch D, Ringquist S, Nickenig G, Andrié R. PLoS One; 2018 Nov 04; 13(3):e0194496. PubMed ID: 29566033 [Abstract] [Full Text] [Related]
12. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death. Amara N, Boveda S, Defaye P, Klug D, Treguer F, Amet D, Perier MC, Gras D, Algalarrondo V, Bouzeman A, Piot O, Deharo JC, Fauchier L, Babuty D, Bordachar P, Sadoul N, Marijon E, Leclercq C, DAI-PP Investigators. Europace; 2018 Jan 01; 20(1):65-72. PubMed ID: 28082419 [Abstract] [Full Text] [Related]
13. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience. Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K. J Cardiol; 2017 Jan 01; 69(1):359-363. PubMed ID: 27595899 [Abstract] [Full Text] [Related]
14. Use of the wearable cardioverter-defibrillator - the Swiss experience. Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Brenner R, Krasniqi N, Müller AS, Dzemali O, Kobza R, Grebmer C, Haegeli L, Berg J, Mayer K, Schläpfer J, Domenichini G, Reichlin T, Roten L, Burri H, Eriksson U, Saguner AM, Steffel J, Duru F, Swiss Wcd Registry. Swiss Med Wkly; 2020 Sep 21; 150():w20343. PubMed ID: 33035354 [Abstract] [Full Text] [Related]
15. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis. Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK. J Heart Lung Transplant; 2015 Oct 21; 34(10):1305-9. PubMed ID: 26094085 [Abstract] [Full Text] [Related]
16. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator. Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG. Pacing Clin Electrophysiol; 2014 May 21; 37(5):562-8. PubMed ID: 24762055 [Abstract] [Full Text] [Related]
17. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort. Zylla MM, Hillmann HAK, Proctor T, Kieser M, Scholz E, Zitron E, Katus HA, Thomas D. Heart Vessels; 2018 Nov 21; 33(11):1390-1402. PubMed ID: 29721674 [Abstract] [Full Text] [Related]
18. Clinical experience with wearable cardioverter defibrillators at a tertiary electrophysiology program. Bossory L, Schubert S, Afzal MR, Weiss R, Tyler J, Kalbfleisch S, Augostini R, Hummel J, Okabe T, Daoud EG, Houmsse M. Pacing Clin Electrophysiol; 2018 Nov 21; 41(11):1491-1494. PubMed ID: 30191582 [Abstract] [Full Text] [Related]
19. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Duncker D, Haghikia A, König T, Hohmann S, Gutleben KJ, Westenfeld R, Oswald H, Klein H, Bauersachs J, Hilfiker-Kleiner D, Veltmann C. Eur J Heart Fail; 2014 Dec 21; 16(12):1331-6. PubMed ID: 25371320 [Abstract] [Full Text] [Related]
20. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions. Forleo GB, Solimene F, Pisanò EC, Zanotto G, Calvi V, Pignalberi C, Maglia G, Iacopino S, Quartieri F, Biffi M, Caravati F, Curnis A, Capucci A, Senatore G, Santamaria M, Della Bella P, Manzo M, Giacopelli D, Gargaro A, D'Onofrio A. J Cardiovasc Electrophysiol; 2019 Sep 21; 30(9):1626-1635. PubMed ID: 31165517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]